Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy

Michelle A.T. Hildebrandt, Hushan Yang, Mien Chie Hung, Julie G. Izzo, Maosheng Huang, Jie Lin, Jaffer A. Ajani, Xifeng Wu

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences